Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT)’s Larimar Therapeutics LRMR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.81M	Buy	+847,644	New	+$3.39M	﹤0.01%	1803
2024 Q2	–	Sell	-89,094	Closed	-$676K	–	4354
2024 Q1	$676K	Buy	+89,094	New	+$694K	﹤0.01%	2371
2023 Q2	–	Sell	-45,782	Closed	-$207K	–	2741
2023 Q1	$207K	Buy	+45,782	New	+$239K	﹤0.01%	1924
2021 Q2	–	Sell	-11,123	Closed	-$163K	–	2580
2021 Q1	$163K	Sell	11,123 -31,800	-74%	-$578K	﹤0.01%	1683
2020 Q4	$919K	Buy	42,923 +5,278	+14%	+$106K	0.01%	901
2020 Q3	$571K	Buy	+37,645	New	+$477K	0.01%	987

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return